Human leukocyte antigen-DQB1 and -DRB1 associations in patients with idiopathic sudden sensorineural hearing loss from a defined population of Northwest Spain

Acta Oto-Laryngologica

Volumn 125, Issue 12, 2005, Pages 1277-1282

  Amor Dorado, Juan C ^a   Paco, Laura ^b   Martin, Javier ^c   Lopez Nevot, Miguel A ^b   Gonzalez Gay, Miguel A ^a  

^a HOSPITAL XERAL CALDE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Disease susceptibility; Genetics; Human leukocyte antigen DQB1; Human leukocyte antigen DRB1; Idiopathic sudden sensorineural hearing loss; Outcome; Treatment

Indexed keywords

DNA; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; METHYLPREDNISOLONE; PENTOXIFYLLINE; PIRACETAM; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; FOLLOW UP; GENE FREQUENCY; GENERAL CONDITION IMPROVEMENT; GENETIC RISK; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HLA TYPING; HUMAN; IDIOPATHIC DISEASE; MALE; PERCEPTION DEAFNESS; PHENOTYPE; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SOCIAL SUPPORT; SPAIN; SYMPTOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; SPAIN;

EID: 28444445619     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480510012228     Document Type: Article

References (20)

1. Koc A, Sanisoglu O. Sudden sensorineural hearing loss: literature survey on recent studies. J Otolaryngol 2003;32:308-13.
2. Shikowitz MJ. Sudden sensorineural hearing loss. Med Clin North Am 1991;75:1239-50.
3. Mattox DE, Lyles CA. Idiopathic sudden sensorineural hearing loss. Am J Otol 1989;10:242-7.
4. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double blind clinical study. Arch Otolaryngol 1980;106:772-6.
5. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
6. Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 2002;31:355-60.
7. Yeo SW, Chang KH, Suh BD, Kim TG, Han H. Distribution of HLA-A, -B and -DRB1 alleles in patients with sudden sensorineural hearing loss. Acta Otolaryngol 2000;120:710-5.
8. Yeo SW, Park SN, Park YS, Suh BD, Han H, Choi HB, et al. Different distribution of HLA class II alleles according to response to corticosteroid therapy in sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2001;127:945-9.
9. Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore) 1999;78:292-308.
10. Amor-Dorado JC, Llorca J, Garcia-Porrua C, Costa C, Perez-Fernandez N, Gonzalez-Gay MA. Audiovestibular manifestations in giant cell arteritis: a prospective study. Medicine (Baltimore) 2003;82:13-26.
11. Monsell EM, Balkany TA, Gates GA, Goldenberg RA, Meyerhoff WA, House JW. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181-5.
12. Gonzalez-Gay MA, Hajeer AH, Garcia-Porrua C, Dababneh A, Thomson W, Ollier WE, et al. Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset. J Rheumatol 2002;29:271-5.
13. Bernstein JM, Shanahan TC, Schaffer FM. Further observations on the role of the MHC genes and certain hearing disorders. Acta Otolaryngol (Stockh) 1996;116:666-71.
14. Cao MY, Thonnard J, Deggouj N, Gersdorff M, Phillippe M, Osselaer JC, et al. HLA class II-associated genetic susceptibility in idiopathic progressive sensorineural hearing loss. Ann Otol Rhinol Laryngol 1996;105:628-33.
15. Hajeer AH, Dababneh A, Makki RF, Thomson W, Poulton K, Gonzalaz-Gay MA, et al. Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. Tissue Antigens 2000;55:319-25.
16. Roep BO, Schipper R, Verduyn W, Bruining GJ, Schreuder GM, de Vries RR. HLA-DRB1*0403 is associated with dominant protection against IDDM in the general Dutch population and subjects with high-risk DQA1*0301- DQB1*0302/DQA1*0501-DQB1*0201 genotype. Tissue Antigens 1999;54:88-90.
17. Donner H, Seidl C, Van der Auwera B, Braun J, Siegmund T, Herwig J. HLA-DRB1*04 and susceptibility to type 1 diabetes mellitus in a German/Belgian family and German case-control study. The Belgian Diabetes Registry. Tissue Antigens 2000;55:271-4.
18. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Hajeer AH, Branas F, Dababneh A, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000;79:283-92.
19. Mu H, Chen JJ, Jiang Y, King M-C, Thomson G, Criswell LA. Tumor necrosis factor a microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRB1 shared epitope. Arthritis Rheum 1999;42:438-42.
20. Mattey DL, Hassell AB, Dawes PT, Ollier WER, Hajeer A. Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis. Influence on disease outcome. Arthritis Rheum 1999;42:2698-704.